Phase II study of idarubicin administered i.v. to pediatric patients with acute lymphoblastic leukemia.

Madon, E; Grazia, G; De Bernardi, B; Comelli, A; Carli, M; Sainati, L; Paolucci, G; Canino, R; Colella, R; Bagnulo, S

Madon, E; Grazia, G; De Bernardi, B; Comelli, A; Carli, M; Sainati, L; Paolucci, G; Canino, R; Colella, R; Bagnulo, S.

Cancer Treat Rep ; 71(9): 855-6, 1987 Sep.

Article in En | MEDLINE | ID: mdl-3476202

Subject(s)

Antibiotics, Antineoplastic/therapeutic use; Daunorubicin/analogs & derivatives; Leukemia, Lymphoid/drug therapy; Adolescent; Antibiotics, Antineoplastic/adverse effects; Child; Child, Preschool; Daunorubicin/adverse effects; Daunorubicin/therapeutic use; Drug Evaluation; Female; Humans; Idarubicin; Infant; Infant, Newborn; Male; Remission Induction

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Lymphoid / Daunorubicin / Antibiotics, Antineoplastic Limits: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male / Newborn Language: En Journal: Cancer Treat Rep Year: 1987 Document type: Article Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links